Free shipping on all orders over $ 500

Ginsenoside-Rk1

Cat. No. M4092
Ginsenoside-Rk1 Structure
Size Price Availability Quantity
5mg USD 110  USD110 In stock
10mg USD 185  USD185 In stock
20mg USD 300  USD300 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Ginsenoside Rk1 is a high-temperature processed extract of ginseng. Ginsenoside Rk1 has anti-inflammatory effects and inhibits Jak2/Stat3 signaling pathway and NF-κB activation. Ginsenoside Rk1 has anti-tumor effects, anti-platelet aggregation activity, anti-inflammatory effects, anti-insulin resistance, renal protection, antibacterial effects, enhanced cognitive function, reduced lipid accumulation and prevention of osteoporosis. Ginsenoside Rk1 induces apoptosis by triggering intracellular reactive oxygen species (ROS) generation and blocking the PI3K/Akt pathway.

Chemical Information
Molecular Weight 766.998
Formula C42H70O12
CAS Number 494753-69-4
Form Solid
Solubility (25°C) 10 mM in DMSO
Storage -20°C, protect from light
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Jian Xiong, et al. Ginsenoside Rk1 protects human melanocytes from H 2 O 2‑induced oxidative injury via regulation of the PI3K/AKT/Nrf2/HO‑1 pathway

[2] Jung-Hae Shin, et al. Ginsenoside Rk1 suppresses platelet mediated thrombus formation by downregulation of granule release and α IIb β 3 activation

[3] Zhiman Li, et al. Ginsenoside Rk1 alleviates LPS-induced depression-like behavior in mice by promoting BDNF and suppressing the neuroinflammatory response

[4] Nayeon Ryoo, et al. Ginsenoside Rk1 is a novel inhibitor of NMDA receptors in cultured rat hippocampal neurons

[5] Manling Hu, et al. Ginsenoside Rk1 induces apoptosis and downregulates the expression of PD-L1 by targeting the NF-κB pathway in lung adenocarcinoma

Related NF-κB Products
Narlumosbart

Narlumosbart is a human IgG4ҡ monoclonal antibody (mAb) that targets Receptor Activating Factor for Nuclear Factor κB Ligand (RANKL) and can be used in studies related to Giant Cell Tumor of Bone (GCTB).

Ac2-26

Ac2-26, an active N-terminal peptide of annexin A1 (AnxA1), attenuates ischemia-reperfusion-induced acute lung injury.

Mitogen-activated protein kinase 1

Mitogen-activated protein kinase 1 (MAPK1) can activate the downstream p38/NF-κB pathway.

IKKγ NBD Inhibitory Peptide

IKKγ NBD Inhibitory Peptide is a highly specific inhibitor NF-κB inhibitor.

Tripeptide-41

Tripeptide-41(CG-Lipoxyn)isa bioactive peptide withreduce fat accumulationeffect and has been reported used as a cosmetic ingredient.

  Catalog
Abmole Inhibitor Catalog




Keywords: Ginsenoside-Rk1 supplier, NF-κB, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.